is hers going to stop selling semaglutide Novo Nordisk has dropped its legal case against telehealth provider Hims & over patent infringement, after the two companies agreed Hims would sell Novo's branded medicines through its platform. 🔗Tap the Novo Nordisk Drops Hims &

10 GLP-1 receptor agonists (GLP-1RAs), or incretin mimetics, are currently among the most promising drugs for adjusting metabolic function, playing significant roles in the management of T2DM, and some have been approved for obesity management

If there is one thing I think the retatrutide era will force coaches to do, it is think more systemically

Diabetes therapy: research, treatment and education of diabetes and related disorders, 14 (4), 749766

References 1 PovoleriGAScottCNova-LampertiEAJohnSLombardiGAfzaliB

HSA and FSA accounts are accepted for payment

Thats the active ingredient in Ozempic (an injectable type 2 diabetes drug) and Wegovy (for people with obesity), and its become internet-and-beyond famous for how much weight people can lose while taking it